Comparative Performance of Stereotactic Body Radiotherapy and Lenvatinib in Unresectable Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis: A Propensity Score-Matched Cohort Analysis.

J Hepatocell Carcinoma · 2026 · PMC13281888 · PMID 42326608

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

did not reach statistical significancep=0.058so close (0.05 < p ≤ 0.1)

After PSM, although the combination group maintained a numerically higher ORR (60.0% vs 40.0%), the difference did not reach statistical significance (p=0.058).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.